Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Antibody therapy

Celltrion Corona 19 Antibody Treatment’Rekirona’ Opened for Export to Europe

Celltrion Corona 19 Antibody Treatment’Rekirona’ Opened for Export to Europe

Ministry of Food and Drug Safety’s advisory group’retired’ from Chong Kun Dang’s corona treatment

Ministry of Food and Drug Safety’s advisory group’retired’ from Chong Kun Dang’s corona treatment

[IBS 코로나19 리포트 시즌2] How far have you come to develop an antibody treatment for COVID-19: Dong-A Science

[IBS 코로나19 리포트 시즌2] How far have you come to develop an antibody treatment for COVID-19: Dong-A Science

When will Celltrion’s corona treatment approval review be completed?

When will Celltrion’s corona treatment approval review be completed?

Celltrion chairman’s remarks “contemplating the development of a vaccine for Corona 19,” the share price is 2%

Celltrion chairman’s remarks “contemplating the development of a vaccine for Corona 19,” the share price is 2%

Seo Jeong-jin, Chairman of Celltrion, “Review of vaccine development in case of short supply”

Seo Jeong-jin, Chairman of Celltrion, “Review of vaccine development in case of short supply”

Supplied the first domestic antibody treatment drug’Rekironaju’ to medical institutions in the middle of this month-Cheonji Ilbo

Supplied the first domestic antibody treatment drug’Rekironaju’ to medical institutions in the middle of this month-Cheonji Ilbo

Final’approved’ of the first domestic treatment…  “Limited Use”

Final’approved’ of the first domestic treatment… “Limited Use”

Celltrion Corona Treatment Recommended for Mild Patients in Moderate and High Risk Groups

Celltrion Corona Treatment Recommended for Mild Patients in Moderate and High Risk Groups

[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent…  Opinion that approval is possible under the premise of Phase 3

[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent… Opinion that approval is possible under the premise of Phase 3

Ministry of Food and Drug Safety’s Central Pharmaceutical Affairs Commission “Recommendation for use of celltrion antibody therapy for moderate and high-risk patients with mild symptoms”: Dong-A Science

Ministry of Food and Drug Safety’s Central Pharmaceutical Affairs Commission “Recommendation for use of celltrion antibody therapy for moderate and high-risk patients with mild symptoms”: Dong-A Science

[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment…  Recovery period ↓

[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment… Recovery period ↓

Older posts
Page1 Page2 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en